Maluf Feres C, Bhatia Ansh, Khandekar Archan, Lopategui Diana M, Porto Joao G, Chen Ryan R, Daher Jean C, Zarli Mohamadhusni, Marcovich Robert, Shah Hemendra N
University of California San Francisco San Francisco CA USA.
Miller School of Medicine Desai Sethi Urology Institute, University of Miami Miami FL USA.
BJUI Compass. 2024 Dec 20;6(1):e469. doi: 10.1002/bco2.469. eCollection 2025 Jan.
To evaluate the safety and feasibility of "en-bloc" Holmium Laser Enucleation of the Prostate (HoLEP) with trainee involvement in patients with prostates larger than 200 cc.
A retrospective analysis was conducted on patients undergoing HoLEP using the "en-bloc" technique for prostate sizes > 200 cc between July-2017 and December-2023 at an academic teaching hospital. Perioperative data was collected, including patient demographics, clinical parameters, operative details and functional outcomes. Patients who continued to experience incontinence at 1 year were further followed up at 2 years to update their continence status. Sub-group analysis was performed to compare outcomes between patients with preoperative prostate size of 200-300 cc and > 300 cc.
The analysis included 89 patients with a mean age of 73.12 ± 8.10 years. Preoperative prostate weight ranged from 200 to 401 cc with a median of 245 cc, and median PSA was 7.71 ng/ml. Median operative time was 218.5 minutes, and median enucleated prostate volume was 164.2 cc. Median postoperative PSA was 0.4 [0.21-0.78] ng/ml. At 1-year follow-up, mean IPSS was 1 ± 2.4, Qmax was 27.03 ± 11.57 ml/s and PVR was 21.6 ± 28.6 ml. Postoperative complications included blood transfusion (5.6%), acute renal injury (4.5%), urinary tract infection (2.2%), postoperative urinary retention (2.2%) and urethral stricture (5%). Although transient urinary incontinence was noted in 41.6% at 1-3-months, complete continence was achieved in 83.3% and 96.3% at 1 and 2 years postoperatively, respectively. Subgroup analysis showed significant differences in operative time and enucleated weight between prostates 200-300 cc and > 300 cc, but no significant differences in postoperative IPSS, PVR or Qmax at 3-months.
"En-bloc" HoLEP is a feasible and safe procedure for prostates larger than 200 cc, demonstrating favourable perioperative and functional outcomes despite the extended operative times and involvement of trainees.
评估在学员参与下,对前列腺体积大于200cc的患者进行“整块”钬激光前列腺剜除术(HoLEP)的安全性和可行性。
对2017年7月至2023年12月期间在一家学术教学医院接受使用“整块”技术的HoLEP治疗、前列腺体积>200cc的患者进行回顾性分析。收集围手术期数据,包括患者人口统计学资料、临床参数、手术细节和功能结局。对术后1年仍有尿失禁的患者在术后2年进一步随访以更新其尿失禁状态。进行亚组分析以比较术前前列腺体积为200 - 300cc和>300cc的患者之间的结局。
分析纳入89例患者,平均年龄为73.12±8.10岁。术前前列腺重量范围为200至401cc,中位数为245cc,中位前列腺特异性抗原(PSA)为7.71ng/ml。中位手术时间为218.5分钟,中位剜除前列腺体积为164.2cc。术后中位PSA为0.4[0.21 - 0.78]ng/ml。在1年随访时,平均国际前列腺症状评分(IPSS)为1±2.4,最大尿流率(Qmax)为27.03±11.57ml/s,残余尿量(PVR)为21.6±28.6ml。术后并发症包括输血(5.6%)、急性肾损伤(4.5%)、尿路感染(2.2%)、术后尿潴留(2.2%)和尿道狭窄(5%)。尽管在术后1 - 三个月有41.6%的患者出现短暂性尿失禁,但分别在术后1年和2年时,83.3%和96.3%的患者实现了完全控尿。亚组分析显示,前列腺体积200 - 300cc和>300cc的患者在手术时间和剜除重量方面存在显著差异,但在术后3个月时的IPSS、PVR或Qmax方面无显著差异。
对于前列腺体积大于200cc的患者,“整块”HoLEP是一种可行且安全的手术,尽管手术时间延长且有学员参与,但围手术期和功能结局良好。